Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

The Children's National Research Institute

Research Profile

Education & Training

  • M.D., Medine, Boston University, Boston, MA, (1970-1976)
  • Residency, Pediatrics, University of Minnesota, Minneapolis, MN, (1976-1979)
  • Fellowship, Cardiology, Columbia University, New York, NY, (1979-1983)

Academic Appointments

  • Professor of Pediatrics, George Washington School of Medicine


Jeffrey Moak, M.D., is the Director of Electrophysiology and Pacing Program in the Children’s National Hospital Division of Cardiology, and he has held the position for more than 20 years. He is a professor at George Washington School of Medicine & Health Sciences. He treats children, adolescents and young adults with cardiac arrhythmias and autonomic nervous system dysfunction.

Dr. Moak’s main interests have centered on cardiac arrhythmias, especially those that occur after open heart surgery, as well as those that appear in healthy children. Currently Dr. Moak and the cardiology team are working on developing non-fluoroscopic techniques for catheter ablation of cardiac arrhythmias in children, non-pharmacologic methods for the control of arrhythmias that occur in the early post-operative period and new methods for the treatment of children and adolescents with Postural Orthostatic Tachycardia Syndrome.

As one of the pioneers in the laser extraction technique, Dr. Moak holds research funding to assess the best transvenous pacing leads to use in children. His interests led him to develop the Clinic for Autonomic Disorders Evaluation (CADE) at Children’s National, which allows for treatment of autonomic nervous system disorders affecting the cardiovascular and gastrointestinal systems. Dr. Moak and his team are initiating a new medical safety initiative assessing the safest practice for the treatment of children with cardiac arrhythmias in the Cardiac Intensive Care Unit. Dr. Moak is a member of the ACC/HRS/AHA committee writing new guidelines for the evaluation and treatment of Syncope and Postural Orthostatic Tachycardia Syndrome.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • Medtronic, INc. 
  • Biosense Webster, Inc. 
  • Boston Scientific 

Research & Publications